1. UCL Home
  2. Research institutes
  3. Louvain Drug Research Institute
  4. Research groups
  5. Biomedical Magnetic Resonance (REMA)
  6. Publications

Publications

Bruxelles Woluwe

 

GALLEZ Bernard

 

  1. Mignion, Lionel ; Desmet, Celine M. ; Harkemanne, Evelyne ; Tromme, Isabelle ; Joudiou, Nicolas ; Wehbi, Mohammad ; Baurain, Jean-François ; Gallez, Bernard. Noninvasive detection of the endogenous free radical melanin in human skin melanomas using electron paramagnetic resonance (EPR). In: Free Radical Biology and Medicine, Vol. 190, no.x, p. 226-233 (2022).
  2. Gallez, Bernard. The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.. In: Frontiers in pharmacology, Vol. 13, no.x, p. 853568 (2022). 
  3. d'Hose, Donatienne ; Danhier, Pierre ; Northshield, Heidi ; Isenborghs, Pauline ; Jordan, Bénédicte ; Gallez, Bernard. A versatile EPR toolbox for the simultaneous measurement of oxygen consumption and superoxide production. In: Redox biology, Vol. 40, no., p. 101852 (2021). 
  4. Schoonjans CA, Joudiou N, Brusa D, Corbet C, Feron O, Gallez B. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate. Cancer Lett. (2020) 470, 18-28
  5. Diepart C., Karroum O., Magat J., Feron O., Verrax J., Buc-Calderon P., Grégoire V., Jordan B., Gallez B. Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res. (2012), 72: 482-490.
JORDAN Bénédicte

 

  1. Yelek, Caner ; Mignion, Lionel ; Paquot, Adrien ; Bouzin, Caroline ; Corbet, Cyril ; Muccioli, Giulio ; Cani, Patrice D. ; Jordan, Bénédicte. Tumor Metabolism Is Affected by Obesity in Preclinical Models of Triple-Negative Breast Cancer. In: Cancers, Vol. 14, no. 3, p. 562 [1-16] (2022). doi:10.3390/cancers14030562.
  2. Farah, Chantale ; Neveu, Marie-Aline ; Yelek, Caner ; Bouzin, Caroline ; Gallez, Bernard ; Baurain, Jean-François ; Mignion, Lionel ; Jordan, Bénédicte. Combined HP 13C Pyruvate and 13C-Glucose Fluxomic as a Potential Marker of Response to Targeted Therapies in YUMM1.7 Melanoma Xenografts. In: Biomedicines, Vol. 10, no. 3, p. 717 (2022).
  3. Mignion L, Acciardo S, Gourgue F, Joudiou N, Caignet X, Goebbels RM, Corbet C, Bouzin C, Cani PD, Machiels JP, Schmitz S, Jordan BF.
    Metabolic imaging using hyperpolarized pyruvate-lactate exchange assesses response or resistance to the EGFR inhibitor cetuximab in patient-derived HNSCC xenografts.
    Clin. Cancer Res (2020), 26(8):1932-1943.
  4. Colliez F., Neveu M.A., Magat J., Cao Pham T.T., Gallez B., Jordan B.F. Qualification of a Noninvasive Magnetic Resonance Imaging Biomarker to Assess Tumor Oxygenation. Clin. Cancer Res. (2014), 20: 5403-5411.
  5. Mignion L., Dutta P., Martinez G.V., Foroutan P., Gillies R.J., Jordan B.F. Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI. Cancer Res. (2013), 74: 686694.